- A Case of Residual Non-Small Cell Lung Cancer Cells Coexisting With Newly Developed Small Cell Lung Cancer Cells in Ascitic Fluid after Chemotherapy for Non-Small Cell Lung Cancer
-
Park SH, Chi HS, Kim YJ, Cho YU, Jang S, Park CJ, Kim SW
- KMID: 1791913
- Ann Lab Med.
- 2014 Mar;34(2):163-165.
- doi: 10.3343/alm.2014.34.2.163
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Chemotherapy for Pancreatic Cancer
-
Kim YT
- KMID: 782973
- Korean J Gastroenterol.
- 2008 Feb;51(2):111-118.
Chemotherapy is expected to play an important role in the treatment of pancreatic cancer because most of pancreatic cancers are being discovered at locally advanced or metastatic stages and recurrence... -
- CITED
-
- Close
- SHARE
-
- Close
- Epidermal Growth Factor Receptor Mutations and the Clinical Outcome in Male Smokers with Squamous Cell Carcinoma of Lung
-
Park SH, Ha SY, Lee JI, Lee H, Sim H, Kim YS, Hong J, Park J, Cho EK, Shin DB, Lee JH
- KMID: 1779162
- J Korean Med Sci.
- 2009 Jun;24(3):448-452.
- doi: 10.3346/jkms.2009.24.3.448
Epidermal growth factor receptor (EGFR) mutations in non-small cell lung cancer (NSCLC) have been reported to be related to certain clinical characteristics (i.e., female, non-smokers with adenocarcinoma) and gefitinib responsiveness.... -
- CITED
-
- Close
- SHARE
-
- Close
- Pemetrexed versus Gefitinib versus Erlotinib in Previously Treated Patients with Non-Small Cell Lung Cancer
-
Hong J, Kyung SY, Lee SP, Park JW, Jung SH, Lee JI, Park SH, Sym SJ, Park J, Cho EK, Shin DB, Lee JH
- KMID: 1776611
- Korean J Intern Med.
- 2010 Sep;25(3):294-300.
- doi: 10.3904/kjim.2010.25.3.294
BACKGROUND/AIMS: The efficacy and safety of pemetrexed, gefitinib, and erlotinib administration in previously treated patients with non-small cell lung cancer (NSCLC) were compared. METHODS: The study patients met the following... -
- CITED
-
- Close
- SHARE
-
- Close
